MR imaging and MR spectroscopy for characterization of cardiomyopathies in adolescents - Preliminary results;MR-bildgebung und MR-spektroskopie zur charakterisierung von kardiomyopathien bei jugendlichen - Erste ergebnisse

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 9, 2007, Pages 932-937

  Beer, Meinrad ^a   Buchner, S ^a   Wirbelauer, J ^a   Fuchs, J ^a   Machann, W ^a   Ritter, C O ^a   Beissert, M ^a   Darge, K ^a   Hahn, D ^a   Kostler H ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cardiac; Children; Echocardiography; MR imaging; MR spectroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; CASE REPORT; CINEANGIOCARDIOGRAPHY; COMPARATIVE STUDY; CONTROLLED STUDY; ENERGY METABOLISM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HUMAN; IMAGE RECONSTRUCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; THREE DIMENSIONAL IMAGING; VOLUNTEER; AGE; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; ECHO PLANAR IMAGING; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART STROKE VOLUME; HYPERTROPHIC CARDIOMYOPATHY; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; ECHO-PLANAR IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; STROKE VOLUME;

EID: 35148845085     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963302     Document Type: Article

References (26)

1. Winter SC, Buist NR. Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine. Am Heart J 2000; 139: 63-69
2. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 13: 1308-1320
3. Charron P, Dubourg O, Desnos M et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 1998; 19: 1377-1382
4. Konno T, Shimizu M, Ino H et al. Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J 2004; 25: 246-251
5. Jung WI, Sieverding L, Breuer J et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998; 97: 2536-2542
6. Crilley JG, Boehm EA, Blair E et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 2003; 41: 1776-1782
7. Nakae I, Mitsunami K Omura T et al. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 2003; 42: 1587-1593
8. Dettmeyer R, Schmidt P, Kandolf R et al. Evolution of dilated cardiomyopathy (DCM) from idiopathic hypertrophic cardiomyopathy (IHCM) vs. inflammatory dilated cardiomyopathy (DCMi): a rare case of sudden death in an 8-year-old boy. Pathol Res Pract 2004; 200: 411-415
9. de Roos A, Doornbos J, Luyten PR et al. Hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging 1992; 2: 711-719
10. Neubauer S, Krabe T, Schindler R et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Circulation 1992; 86: 1810-1818
11. Lamb HJ, Beyerbacht HP, van der Laarse A et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 1999; 99: 2261-2267
12. Von Kienlin M, Mejia R. Spectral localization with optimal pointspread function. J Magn Reson 1991; 94: 268-287
13. Beer M, Landschütz W, Meininger M et al. Quantifizierung energiereicher Phosphate im gesunden und geschädigten Herzmuskel mittels SLOOP 31P-MR-Spektroskopie. Fortschr Röntgenstr 1999; 170: 65-68
14. Sandstede J, Lipke C, Beer M et al. CINE-MRT zur Untersuchung der Auswirkungen regionaler linksventrikulärer Wandbewegungsstörungen auf die globale Herzfunktion nach Herzinfarkt und Revaskularisierung. Fortschr Röntgenstr 1999; 171: 424-430
15. Vanhamme L, van den Boogaart A, van Huffei S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 35-43
16. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 2007; 356: 1140-1151
17. Neubauer S, Horn M, Cramer M et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190-2196
18. Crilley JG, Boehm EA, Rajagopalan B et al. Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy. J Am Coll Cardiol 2000; 36: 1953-1958
19. Waltimann T, Wyss M, Brdiczka D et al. Intracellular compartmentation, structure, and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis. Biochem J 1992; 281: 21-40
20. Beer M, Seyfarth T, Sandstede J et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002; 40: 1267-1274
21. Okada M, Mitsunami K Inubushi T et al. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorous metabolites measured by 31P-MRS. Magn Reson Med 1998; 39: 772-782
22. Koestler H, Landschutz W, Koeppe S et al. Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy. Magn Reson Med 2006; 56: 907-911
23. Mahnken AH, Günther RW, Krombach G. Kontrastangehobene MRT und MSCT zur kardialen Vitalitätsdiagnostik. Fortschr Röntgenstr 2006; 178: 771-780
24. Heuschmid M, Rothfuss J, Schröder S et al. Bestimmung linksventrikulärer Funktionsparameter: Vergleich von 16-Zeilen-Mehrschicht- CT mit der MR-Tomografie. Fortschr Röntgenstr 2005; 177: 60-66
25. Miller S, Riessen R. MR-tomografische Diagnostik von Kardiomyopathien. Fortschr Röntgenstr 2005; 177: 1497-1505
26. Glüer CC, Barkmann R, Hahn HK et al. Parametrische biomedizinische Bildgebung - was macht die Qualität quantitativer radiologischer Verfahren aus? Fortschr Röntgenstr 2006; 178: 1187-1201